{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:08:14Z","timestamp":1761844094288},"reference-count":37,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Regulatory Peptides"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.regpep.2011.05.008","type":"journal-article","created":{"date-parts":[[2011,6,14]],"date-time":"2011-06-14T11:23:53Z","timestamp":1308050633000},"page":"57-61","source":"Crossref","is-referenced-by-count":20,"title":["Impact of atorvastatin on serum vaspin levels in hypercholesterolemic patients with moderate cardiovascular risk"],"prefix":"10.1016","volume":"170","author":[{"given":"Nikolaos P.E.","family":"Kadoglou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ioannis S.","family":"Vrabas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alkistis","family":"Kapelouzou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stylianos","family":"Lampropoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolaos","family":"Sailer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alkiviadis","family":"Kostakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christos D.","family":"Liapis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.regpep.2011.05.008_bb0005","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1055\/s-0029-1192044","article-title":"Adipose tissue dysfunction in obesity","volume":"117","author":"Bl\u00fcher","year":"2009","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.regpep.2011.05.008_bb0010","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1365-2265.2006.02474.x","article-title":"The endocrine function of adipose tissue: an update","volume":"64","author":"Ronti","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.regpep.2011.05.008_bb0015","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1210\/jc.2004-0395","article-title":"Adipose tissue as an endocrine organ","volume":"89","author":"Kershaw","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.regpep.2011.05.008_bb0020","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1517\/13543784.17.3.327","article-title":"Vaspin: a novel serpin with insulin-sensitizing effects","volume":"17","author":"Wada","year":"2008","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.regpep.2011.05.008_bb0025","doi-asserted-by":"crossref","first-page":"10610","DOI":"10.1073\/pnas.0504703102","article-title":"Visceral adipose tissue-derived serine protease inhibitor: a unique insulin-sensitizing adipocytokine in obesity","volume":"102","author":"Hida","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.regpep.2011.05.008_bb0030","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.bbrc.2005.11.039","article-title":"Vaspin gene expression in human adipose tissue: association with obesity and type 2 diabetes","volume":"339","author":"Kl\u00f6ting","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.regpep.2011.05.008_bb0035","doi-asserted-by":"crossref","first-page":"372","DOI":"10.2337\/db07-1045","article-title":"Serum vaspin concentrations in human obesity and type 2 diabetes","volume":"57","author":"Youn","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.regpep.2011.05.008_bb0040","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.atherosclerosis.2008.08.028","article-title":"Vaspin serum concentrations in patients with carotid stenosis","volume":"204","author":"Aust","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.regpep.2011.05.008_bb0045","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1126\/science.1097243","article-title":"Visfatin: a protein secreted by visceral fat that mimics the effects of insulin","volume":"307","author":"Fukuhara","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.regpep.2011.05.008_bb0050","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.metabol.2009.08.005","article-title":"Effects of rosiglitazone and metformin treatment on apelin, visfatin, and ghrelin levels in patients with type 2 diabetes mellitus","volume":"59","author":"Kadoglou","year":"2010","journal-title":"Metabolism"},{"key":"10.1016\/j.regpep.2011.05.008_bb0055","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1055\/s-0029-1237360","article-title":"Novel markers of carotid atherosclerosis in patients with type 2 diabetes","volume":"118","author":"Kadoglou","year":"2010","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.regpep.2011.05.008_bb0060","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ejphar.2007.09.019","article-title":"Effect of rosuvastatin treatment on plasma visfatin levels in patients with primary hyperlipidemia","volume":"14","author":"Kostapanos","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.regpep.2011.05.008_bb0065","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1517\/14656566.9.11.1829","article-title":"Effects of ezetimibe, either alone or in combination with atorvastatin, on serum visfatin levels: a pilot study","volume":"9","author":"Derdemezis","year":"2008","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.regpep.2011.05.008_bb0070","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/clc.4960270105","article-title":"Marked low-density lipoprotein cholesterol reduction below current national cholesterol education program targets provides the greatest reduction in carotid atherosclerosis","volume":"27","author":"Kent","year":"2004","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.regpep.2011.05.008_bb0075","doi-asserted-by":"crossref","first-page":"479","DOI":"10.2174\/138161209787315729","article-title":"Pleiotropic effects of statins\u2014clinical evidence","volume":"15","author":"Athyros","year":"2009","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.regpep.2011.05.008_bb0080","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1161\/CIRCULATIONAHA.109.192617","volume":"120","author":"Redberg","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.regpep.2011.05.008_bb0085","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","volume":"106","author":"National Cholesterol Education Program (NCEP)","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.regpep.2011.05.008_bb0090","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1055\/s-0030-1265174","article-title":"Effects of rosiglitazone\/metformin fixed-dose combination therapy and metformin monotherapy on serum vaspin, adiponectin and IL-6 levels in drug-na\u00efve patients with type 2 diabetes","volume":"119","author":"Kadoglou","year":"2011","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.regpep.2011.05.008_bb0095","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/hr.2010.85","article-title":"Differential effects of candesartan and olmesartan on adipose tissue activity biomarkers in type II diabetic hypertensive patients","volume":"33","author":"Derosa","year":"2010","journal-title":"Hypertens Res"},{"key":"10.1016\/j.regpep.2011.05.008_bb0100","article-title":"Variation of inflammatory parameters after sibutramine treatment compared to placebo in type 2 diabetic patients","author":"Sailer","year":"2010","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.regpep.2011.05.008_bb0105","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1159\/000321637","article-title":"Serum vaspin concentrations are decreased after exercise-induced oxidative stress","volume":"3","author":"Oberbach","year":"2010","journal-title":"Obes Facts"},{"key":"10.1016\/j.regpep.2011.05.008_bb0110","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/ijo.2010.196","article-title":"Vaspin is related to gender, puberty and deteriorating insulin sensitivity in children","volume":"35","author":"K\u00f6rner","year":"2011","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.regpep.2011.05.008_bb0115","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.metabol.2010.04.008","article-title":"Vaspin and visfatin\/Nampt are interesting interrelated adipokines playing a role in the pathogenesis of type 2 diabetes mellitus","volume":"60","author":"El-Mesallamy","year":"2011","journal-title":"Metabolism"},{"key":"10.1016\/j.regpep.2011.05.008_bb0120","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s12020-009-9234-7","article-title":"Role of adipocytokines in predicting the development of diabetes and its late complications","volume":"36","author":"Gulcelik","year":"2009","journal-title":"Endocrine"},{"key":"10.1016\/j.regpep.2011.05.008_bb0125","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1155\/2010\/535918","article-title":"Inflammation, a link between obesity and cardiovascular disease","volume":"2010","author":"Wang","year":"2010","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.regpep.2011.05.008_bb0130","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1471-2350-12-60","article-title":"New adipokines vaspin and omentin. Circulating levels and gene expression in adipose tissue from morbidly obese women","volume":"12","author":"Auguet","year":"2011","journal-title":"BMC Med Genet"},{"key":"10.1016\/j.regpep.2011.05.008_bb0135","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.arcmed.2010.08.012","article-title":"Serum adiponectin and vaspin levels in rheumatoid arthritis","volume":"41","author":"Ozgen","year":"2010","journal-title":"Arch Med Res"},{"key":"10.1016\/j.regpep.2011.05.008_bb0140","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1292\/jvms.71.1201","article-title":"Vaspin can not inhibit TNF-alpha-induced inflammation of human umbilical vein endothelial cells","volume":"71","author":"Fu","year":"2009","journal-title":"J Vet Med Sci"},{"key":"10.1016\/j.regpep.2011.05.008_bb0145","doi-asserted-by":"crossref","unstructured":"Kim SM, Cho GJ, Yannakoulia M, Hwang TG, Kim IH, Park EK, Mantzoros CS. Lifestyle modification increases circulating adiponectin concentrations but does not change vaspin concentrations. Metabolism 2011. [Epub ahead of print].","DOI":"10.1016\/j.metabol.2011.01.013"},{"key":"10.1016\/j.regpep.2011.05.008_bb0150","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.cca.2010.09.012","article-title":"Serum levels of vaspin and visfatin in patients with coronary artery disease\u2014Kozani study","volume":"412","author":"Kadoglou","year":"2011","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.regpep.2011.05.008_bb0155","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/CRD.0b013e3181f52a7f","article-title":"The pleiotropic effects of the hydroxy-methyl-glutaryl-CoA reductase inhibitors in cardiovascular disease: a comprehensive review","volume":"18","author":"Mihos","year":"2010","journal-title":"Cardiol Rev"},{"key":"10.1016\/j.regpep.2011.05.008_bb0160","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1055\/s-2007-985867","article-title":"Visfatin: a putative biomarker for metabolic syndrome is not influenced by pioglitazone or simvastatin treatment in nondiabetic patients at cardiovascular risk\u2014results from the PIOSTAT study","volume":"39","author":"Pf\u00fctzner","year":"2007","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.regpep.2011.05.008_bb0165","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1365-2265.2008.03453.x","article-title":"Association of plasma visfatin levels with inflammation, atherosclerosis and acute coronary syndromes (ACS) in humans","volume":"71","author":"Liu","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.regpep.2011.05.008_bb0170","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1161\/CIRCULATIONAHA.106.665893","article-title":"Increased expression of visfatin in macrophages of human unstable carotid and coronary atherosclerosis: possible role in inflammation and plaque destabilization","volume":"115","author":"Dahl","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.regpep.2011.05.008_bb0175","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.4049\/jimmunol.178.3.1748","article-title":"Visfatin, an adipocytokine with proinflammatory and immunomodulating properties","volume":"178","author":"Moschen","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.regpep.2011.05.008_bb0180","unstructured":"Agueda M, Lasa A, Simon E, Ares R, Larrarte E, Labayen I. Association of circulating visfatin concentrations with insulin resistance and low-grade inflammation after dietary energy restriction in Spanish obese non-diabetic women: role of body composition changes. Nutr Metab Cardiovasc Dis 2010. [Epub ahead of print]."},{"key":"10.1016\/j.regpep.2011.05.008_bb0185","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1038\/oby.2010.60","article-title":"Effects of weight reduction on serum vaspin concentrations in obese subjects: modification by insulin resistance","volume":"18","author":"Chang","year":"2010","journal-title":"Obesity (Silver Spring)"}],"container-title":["Regulatory Peptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167011511000942?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167011511000942?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,7]],"date-time":"2024-04-07T14:40:18Z","timestamp":1712500818000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167011511000942"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":37,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S0167011511000942"],"URL":"https:\/\/doi.org\/10.1016\/j.regpep.2011.05.008","relation":{},"ISSN":["0167-0115"],"issn-type":[{"type":"print","value":"0167-0115"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}